XOMA Co. (NASDAQ:XOMAO) Sees Significant Drop in Short Interest

XOMA Co. (NASDAQ:XOMAO) was the recipient of a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 100 shares, a decrease of 96.0% from the October 31st total of 2,500 shares. Based on an average trading volume of 5,200 shares, the short-interest ratio is presently 0.0 days.

XOMA Stock Up 0.4 %

XOMAO opened at $25.36 on Friday. The company has a 50 day moving average of $25.53 and a 200 day moving average of $25.33. XOMA has a 12 month low of $22.06 and a 12 month high of $25.87.

About XOMA

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.